ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – TLX

New York, New York–(Newsfile Corp. – December 9, 2025) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) between February 21, 2025 and August 28, 2025, both dates inclusive (the “Class Period”), of the important January 9, 2026 lead plaintiff deadline in the securities […]

Inside the Luxury Event Stylist Celebrities Are Quietly Booking for Proposals, Parties & Premieres

San Diego-based designer and entrepreneur Brittany Williams, Owner, CEO, President, and Lead Designer of Designed for Luxury, is redefining what it means to create memorable, elevated experiences. After spending half her life decorating for loved ones and those in need, Williams has transformed her passion into a thriving, full-service event design company known for crafting

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Tvardi To Contact Him Directly To Discuss Their Options If you suffered significant losses in Tvardi stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or

AVTR DEADLINE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Avantor, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AVTR

New York, New York–(Newsfile Corp. – December 9, 2025) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Avantor, Inc. (NYSE: AVTR) between March 5, 2024 and October 28, 2025, both dates inclusive (the “Class Period”), of the important December 29, 2025 lead plaintiff deadline. SO WHAT: If

Ascend Performance Materials Announces Confirmation of Restructuring Plan

Company expected to emerge from Chapter 11 in coming weeks as financially stronger company Ascend Performance Materials, a leading producer of high-performance and durable engineered materials for everyday essentials and new technologies, announced today the United States Bankruptcy Court for the Southern District of Texas has confirmed the Company's Plan of Reorganization (the “Plan”). This

ROSEN, LEADING TRIAL ATTORNEYS, Encourages Synopsys, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SNPS

New York, New York–(Newsfile Corp. – December 9, 2025) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Synopsys, Inc. (NASDAQ: SNPS) between December 4, 2024 and September 9, 2025, both dates inclusive (the “Class Period”), of the important December 30, 2025 lead plaintiff deadline. SO WHAT: If

Red White & Bloom Brands Closes Debt Settlement

(CNSX:RWB),(CNSX:RWB.CN), TORONTO, Dec. 09, 2025 (GLOBE NEWSWIRE) — Red White & Bloom Brands Inc. (CSE: RWB) (“RWB” or the “Company“) announces that, further to its news release dated December 1, 2025, it has issued 375,000 common shares at a deemed price of $0.035 per share to a former consultant to settle certain outstanding obligations for

Red White & Bloom Brands Closes Debt Settlement

Red White & Bloom Brands Closes Debt Settlement GlobeNewswire December 10, 2025 TORONTO, Dec. 09, 2025 (GLOBE NEWSWIRE) — Red White & Bloom Brands Inc. (CSE: RWB) (“RWB” or the “Company“) announces that, further to its news release dated December 1, 2025, it has issued 375,000 common shares at a deemed price of $0.035 per

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In MoonLake To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in MoonLake between March 10, 2024 and September 29, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh

Lee’s Pharmaceutical Holdings Limited Acquires Staccato® One Breath Technology® Platform and Assets, Driving Pipeline Expansion and Advancing Global Partnership with UCB Through Acquired Rights

— Acquisition of Staccato® One Breath Technology®, a proprietary platform technology with broad therapeutic potential — Synergistic and complementary to Lee'sPharm's existing products pipeline, and — Acquisition of rights as licensor and manufacturer of Staccato®alprazolam under a global partnership with UCB NovaPneuma Inc. (“NPI”), the Delaware incorporated and wholly owned subsidiary of Lee's Pharmaceutical Holdings

Scroll to Top